Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

ADVM Adverum Biotechnologies Inc

6,73

0,17 (2,59%)

22 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form D - Notice of Exempt Offering of Securities

Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Adverum Biotechnologies Charts.

Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Adverum Biotechnologies Charts.

News Adverum Biotechnologies Inc

Form 8-K - Current report
Dienstag 18 Juni 2024 (5 Tage vor) • Edgar (US Regulatory)

Adverum Biotechnologies to Participate in TD Cowen’s Genetic Medicines & RNA Summit
Dienstag 18 Juni 2024 (5 Tage vor) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Dienstag 11 Juni 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 11 Juni 2024 (2 Wochen vor) • Edgar (US Regulatory)

Adverum Biotechnologies Announces Appointments of Dr. Rabia Gurses Ozden as Chief Medical Officer and Dr. Szilárd Kiss as a Member of the Board of Directors
Dienstag 11 Juni 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Dienstag 28 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
Donnerstag 9 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Adverum Biotechnologies to Participate in Upcoming May Investor Conferences
Freitag 3 Mai 2024 (2 Monate vor) • GlobeNewswire Inc.

Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting
Donnerstag 25 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pipeline Highlights and Corporate Updates
Montag 18 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Adverum Biotechnologies Inc News-Artikel

Deutsche Telekom (QX)

Financial Select Sector

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen